Form 4 for FLNA FILANA THERAPEUTICS, INC.
Accepted 2024-04-25 00:00:00 ET · period of report 2024-04-23 · accession 0001437749-24-013144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-04-25 | 2024-04-23 | FLNA | Barry Richard | Dir | M - OptEx | $22.00 | +176.1K | 469.6K | +60% | +$3.87M |
| DI | 2024-04-25 | 2024-01-03 | FLNA | Barry Richard | Dir | A - Grant | $0.00 | +117.4K | 176.1K | +200% | $0 |
| DI | 2024-04-25 | 2024-04-23 | FLNA | Barry Richard | Dir | M - OptEx | $0.00 | -117.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-23 | M | A | 176,085 | $22.00 | 469,562 | I By Trust | — | — | (F2) Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised. |
| 2 | Derivative | Common Stock Warrant | 2024-01-03 | A | A | 117,390 | $0.00 | 176,085 | I By Trust | $33.00 · 2024-01-03 to 2024-05-07 | 176,085 Common Stock | (F1) Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16. |
| 3 | Derivative | Common Stock Warrant | 2024-04-23 | M | D | 117,390 | $0.00 | 0 | I By Trust | $33.00 · 2024-01-03 to 2024-05-07 | 176,085 Common Stock |